Dextran sulfate sodium (TikoMed)

N/A

Report date: 2025/06/27 20:00:57

Base Information

Drug NameDextran sulfate sodium (TikoMed)
Drug Alias NameDSSS5Low molecular weight dextran sulfateIBsolvMIRDextran sulfateTM-400 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor inhibitorsComplement system proteins inhibitorsStem cells modulators +[5] 
TargetsIntracellular signaling peptides and proteinsComplement system proteinsCoagulation factor
Therapy Area/IndicationsDiabetes Mellitus, Type 1Motor Neuron DiseaseAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenNetherlandsNorway +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTikomed AbUppsala Universitet
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of BirminghamNational Institute Of Allergy And Infectious Diseases (Niaid)Tikomed Ab
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1Motor Neuron DiseaseAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksKEGG